Literature DB >> 27888287

Wnt signaling and cellular metabolism in osteoblasts.

Courtney M Karner1,2,3, Fanxin Long4,5.   

Abstract

The adult human skeleton is a multifunctional organ undergoing continuous remodeling. Homeostasis of bone mass in a healthy adult requires an exquisite balance between bone resorption by osteoclasts and bone formation by osteoblasts; disturbance of such balance is the root cause for various bone disorders including osteoporosis. To develop effective and safe therapeutics to modulate bone formation, it is essential to elucidate the molecular mechanisms governing osteoblast differentiation and activity. Due to their specialized function in collagen synthesis and secretion, osteoblasts are expected to consume large amounts of nutrients. However, studies of bioenergetics and building blocks in osteoblasts have been lagging behind those of growth factors and transcription factors. Genetic studies in both humans and mice over the past 15 years have established Wnt signaling as a critical mechanism for stimulating osteoblast differentiation and activity. Importantly, recent studies have uncovered that Wnt signaling directly reprograms cellular metabolism by stimulating aerobic glycolysis, glutamine catabolism as well as fatty acid oxidation in osteoblast-lineage cells. Such findings therefore reveal an important regulatory axis between bone anabolic signals and cellular bioenergetics. A comprehensive understanding of osteoblast metabolism and its regulation is likely to reveal molecular targets for novel bone therapies.

Entities:  

Keywords:  Bone; Fatty acids; Glucose; Glutamine; Metabolism; Osteoblast; Wnt; mTORC1; mTORC2

Mesh:

Substances:

Year:  2016        PMID: 27888287      PMCID: PMC5380548          DOI: 10.1007/s00018-016-2425-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  150 in total

1.  Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1.

Authors:  J Roose; G Huls; M van Beest; P Moerer; K van der Horn; R Goldschmeding; T Logtenberg; H Clevers
Journal:  Science       Date:  1999-09-17       Impact factor: 47.728

2.  Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.

Authors:  Frederic Morvan; Kim Boulukos; Philippe Clément-Lacroix; Sergio Roman Roman; Isabelle Suc-Royer; Béatrice Vayssière; Patrick Ammann; Patrick Martin; Sonia Pinho; Philippe Pognonec; Patrick Mollat; Christof Niehrs; Roland Baron; Georges Rawadi
Journal:  J Bone Miner Res       Date:  2006-06       Impact factor: 6.741

3.  Aerobic glycolysis in bone: lactate production and gradients in calvaria.

Authors:  W F Neuman; M W Neuman; R Brommage
Journal:  Am J Physiol       Date:  1978-01

4.  Carnitine and dehydroepiandrosterone sulfate induce protein synthesis in porcine primary osteoblast-like cells.

Authors:  K M Chiu; E T Keller; T D Crenshaw; S Gravenstein
Journal:  Calcif Tissue Int       Date:  1999-06       Impact factor: 4.333

5.  Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation.

Authors:  Jianwen Wei; Junko Shimazu; Munevver P Makinistoglu; Antonio Maurizi; Daisuke Kajimura; Haihong Zong; Takeshi Takarada; Takashi Lezaki; Jeffrey E Pessin; Eiichi Hinoi; Gerard Karsenty
Journal:  Cell       Date:  2015-06-18       Impact factor: 41.582

6.  β-catenin promotes bone formation and suppresses bone resorption in postnatal growing mice.

Authors:  Jianquan Chen; Fanxin Long
Journal:  J Bone Miner Res       Date:  2013-05       Impact factor: 6.741

7.  Control of bone formation by the serpentine receptor Frizzled-9.

Authors:  Joachim Albers; Jochen Schulze; F Timo Beil; Matthias Gebauer; Anke Baranowsky; Johannes Keller; Robert P Marshall; Kristofer Wintges; Felix W Friedrich; Matthias Priemel; Arndt F Schilling; Johannes M Rueger; Kerstin Cornils; Boris Fehse; Thomas Streichert; Guido Sauter; Franz Jakob; Karl L Insogna; Barbara Pober; Klaus-Peter Knobeloch; Uta Francke; Michael Amling; Thorsten Schinke
Journal:  J Cell Biol       Date:  2011-03-14       Impact factor: 10.539

8.  Lrp5 functions in bone to regulate bone mass.

Authors:  Yajun Cui; Paul J Niziolek; Bryan T MacDonald; Cassandra R Zylstra; Natalia Alenina; Daniel R Robinson; Zhendong Zhong; Susann Matthes; Christina M Jacobsen; Ronald A Conlon; Robert Brommage; Qingyun Liu; Faika Mseeh; David R Powell; Qi M Yang; Brian Zambrowicz; Han Gerrits; Jan A Gossen; Xi He; Michael Bader; Bart O Williams; Matthew L Warman; Alexander G Robling
Journal:  Nat Med       Date:  2011-05-22       Impact factor: 53.440

9.  Dishevelled activates Ca2+ flux, PKC, and CamKII in vertebrate embryos.

Authors:  Laird C Sheldahl; Diane C Slusarski; Petra Pandur; Jeffrey R Miller; Michael Kühl; Randall T Moon
Journal:  J Cell Biol       Date:  2003-05-26       Impact factor: 10.539

10.  WNT7B promotes bone formation in part through mTORC1.

Authors:  Jianquan Chen; Xiaolin Tu; Emel Esen; Kyu Sang Joeng; Congxin Lin; Jeffrey M Arbeit; Markus A Rüegg; Michael N Hall; Liang Ma; Fanxin Long
Journal:  PLoS Genet       Date:  2014-01-30       Impact factor: 5.917

View more
  70 in total

1.  Inducible expression of Wnt7b promotes bone formation in aged mice and enhances fracture healing.

Authors:  Deye Song; Guangxu He; Fangfang Song; Zhepeng Wang; Xiaochen Liu; Lele Liao; Jiangdong Ni; Matthew J Silva; Fanxin Long
Journal:  Bone Res       Date:  2020-02-03       Impact factor: 13.567

Review 2.  Glucose metabolism in bone.

Authors:  Courtney M Karner; Fanxin Long
Journal:  Bone       Date:  2017-08-24       Impact factor: 4.398

Review 3.  Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis.

Authors:  Eben G Estell; Clifford J Rosen
Journal:  Nat Rev Endocrinol       Date:  2020-11-04       Impact factor: 43.330

Review 4.  Mechanical, hormonal and metabolic influences on blood vessels, blood flow and bone.

Authors:  Rhonda D Prisby
Journal:  J Endocrinol       Date:  2017-08-16       Impact factor: 4.286

5.  Circulating microRNAs, miR-10b-5p, miR-328-3p, miR-100 and let-7, are associated with osteoblast differentiation in osteoporosis.

Authors:  Ruisong Chen; Xin Liao; Fengrong Chen; Bowen Wang; Jianming Huang; Guojian Jian; Zheyuan Huang; Ganghui Yin; Haoyuan Liu; Dadi Jin
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

6.  Loss of Nmp4 optimizes osteogenic metabolism and secretion to enhance bone quality.

Authors:  Yu Shao; Emily Wichern; Paul J Childress; Michele Adaway; Jagannath Misra; Angela Klunk; David B Burr; Ronald C Wek; Amber L Mosley; Yunlong Liu; Alexander G Robling; Nickolay Brustovetsky; James Hamilton; Kylie Jacobs; Deepak Vashishth; Keith R Stayrook; Matthew R Allen; Joseph M Wallace; Joseph P Bidwell
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-01-15       Impact factor: 4.310

7.  Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome.

Authors:  Je-Hwan Lee; Stefan Faderl; John M Pagel; Chul Won Jung; Sung-Soo Yoon; Animesh D Pardanani; Pamela S Becker; Howard Lee; Jeongeun Choi; Kyoungjune Lee; Minkyoung Kim; Jorge E Cortes
Journal:  Blood Adv       Date:  2020-05-12

8.  Global MicroRNA Profiling in Human Bone Marrow Skeletal-Stromal or Mesenchymal-Stem Cells Identified Candidates for Bone Regeneration.

Authors:  Chi-Chih Chang; Morten T Venø; Li Chen; Nicholas Ditzel; Dang Q S Le; Philipp Dillschneider; Moustapha Kassem; Jørgen Kjems
Journal:  Mol Ther       Date:  2017-12-05       Impact factor: 11.454

Review 9.  Energy metabolism: A newly emerging target of BMP signaling in bone homeostasis.

Authors:  Jingwen Yang; Hiroki Ueharu; Yuji Mishina
Journal:  Bone       Date:  2020-06-05       Impact factor: 4.398

10.  Effect of kirenol on the interaction between the WNT/β-Catenin and RUNX2/TCF/LEF1 pathways in fracture healing in vivo.

Authors:  İbrahim Karaman; Ali Eray Günay; Mükerrem Betül Yerer; Eren Demirpolat; Serap Doğan; Arzu Hanım Yay; İbrahim Halil Kafadar
Journal:  Acta Orthop Traumatol Turc       Date:  2020-05       Impact factor: 1.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.